Cerebral IPO
Cerebral is a mental health platform that provides online therapy and psychiatric services, including medication management and counseling sessions. The company aimed to make mental healthcare more accessible through its subscription-based telehealth model. However, the company has faced regulatory scrutiny and operational challenges that have impacted its growth trajectory and market position.
Key Facts
| Industry | Digital Mental Health |
| Founded | 2020 |
| Headquarters | San Francisco, CA |
| Employees | ~1,000 |
| Website | cerebral.com |
| Funding | Series C at $4.8B valuation. Total raised: ~$462M |
About Cerebral
Cerebral is a digital mental health platform that provides online therapy, psychiatry, and medication management services through a subscription-based model. The company offers treatment for conditions including depression, anxiety, ADHD, and insomnia through a combination of licensed therapists, psychiatric providers, and proprietary technology tools. Cerebral gained significant traction during the COVID-19 pandemic as demand for telehealth mental health services surged. However, the company faced regulatory scrutiny and controversy over its prescribing practices, particularly regarding controlled substances like Adderall for ADHD treatment. This led to leadership changes, regulatory investigations, and a significant scaling back of operations. The company has had to restructure its business model and prescribing protocols while facing increased competition in the crowded digital mental health space.
IPO Status
Cerebral has not announced IPO plans and remains a private company, though its path to going public has become significantly more complicated due to various challenges. The company raised substantial funding in 2021, reaching a valuation of over $4 billion, but has since faced regulatory investigations, leadership changes, and operational difficulties. The company has had to scale back some operations and has faced scrutiny over its prescribing practices. Given the regulatory challenges and internal restructuring the company has undergone, any potential IPO appears unlikely in the near term. The company would likely need to resolve ongoing regulatory matters and demonstrate stable operations before considering a public offering. The broader market sentiment toward telehealth companies has also become more cautious, making the IPO environment more challenging for companies in this sector.
Competitors
Frequently Asked Questions
Does Cerebral have a stock?
No, Cerebral has not had an IPO and remains privately held. The mental health platform has faced significant operational and regulatory challenges that make an IPO unlikely in the near term.
When is the Cerebral IPO date?
Cerebral has not announced an IPO date, and given the company's recent challenges, there are no confirmed details about potential public offering plans.
How can I buy Cerebral stock?
Cerebral stock is not available for purchase as it remains a private company. Any potential stock availability would depend on the company successfully going public in the future.
Stay Updated on the Cerebral IPO
Get real-time alerts when Cerebral files for an IPO, prices shares, or begins trading.
Get IPO Alerts